Table S2.
miRNA | Franklin, 2018 6 | Duell, 2017 7 | Johansen, 2016 11 | Alemar, 2016 13 | Slater, 2014 18 | Ganepola, 2014 20 | Liu.R, 2012 23 | Liu.J.Q, 2012 24 | Wang, 2009 25 | Number Of Studies |
---|---|---|---|---|---|---|---|---|---|---|
miR-21 | ○↑ | ○↑ | ○↑ | ○↑ | 4 | |||||
miR-24 | ○↑ | ○- | ○↑ | 3 | ||||||
miR-196a | ○↑ | ○↑ | ○↑ | 3 | ||||||
miR-106b | ○↓ | ○↑ | 2 | |||||||
miR-25 | ○- | ○↑ | 2 | |||||||
miR-155 | ○↑ | ○↑ | 2 | |||||||
miR-34a | ○↑ | ○↑ | 2 | |||||||
miR-191 | ○ | ○↑ | 2 | |||||||
miR-20a | ○- | ○↑ | 2 | |||||||
miR-885-5p | ○↑ | ○↑ | 2 |
Notes: ○ represents miRNAs which are part of a panel; ↑ represents upregulation; ↓ represents down-regulation; - represents no difference in overall study population.